Rhythm Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
33.67
|
|
Average Rating
|
4.33
|
|
# Strong Buys
|
5
|
|
# Buys
|
2
|
|
# Holds
|
2
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-1.00
|
-0.79
|
0.21
|
21.00%
|
|
2022-06-30
|
-0.95
|
-0.89
|
0.06
|
6.32%
|
|
2022-03-31
|
-1.01
|
-1.05
|
-0.04
|
-3.96%
|
|
2021-12-31
|
-0.91
|
-0.85
|
0.06
|
6.59%
|
|
2021-09-30
|
-0.81
|
-0.70
|
0.11
|
13.58%
|
|
2021-06-30
|
-0.68
|
-0.70
|
-0.02
|
-2.94%
|
|
2021-03-31
|
0.30
|
0.90
|
0.60
|
200.00%
|
|
2020-12-31
|
-0.80
|
-0.79
|
0.01
|
1.25%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-2.73
|
|
2021-12-31
|
-1.35
|
|
2020-12-31
|
-3.05
|
|
2019-12-31
|
-3.90
|
|
2018-12-31
|
-2.38
|
|
2017-12-31
|
-2.62
|